In this episode of BioTalk with Rich Bendis, we’re joined by three guests from Solaxa: CEO & Founder Christian Walker, Chief Operating Officer Luis T. Gutierrez, Jr., and Chief Commercial Officer Jennifer Butler. Solaxa is a pioneering biotech company with a mission to revolutionize the treatment of cerebellar ataxias and acute nerve injuries caused by trauma and chemotherapy.
Discover the compelling story behind Solaxa’s choice to establish its roots in Montgomery County and how the BioHealth Capital Region has played a crucial role in its growth. Learn how Solaxa’s team was assembled, including the inspiring success stories of Luis and Jennifer, both part of the BioHealth Innovation and Montgomery County Maryland’s Executive in Residence program.
Hear how Solaxa is making a difference in the world of neurology with SLX-001, a drug showing immense promise in treating cerebellar ataxias. Dive into their innovative approach, including the development of their treatment for cerebellar ataxias.
Additionally, discover how Solaxa’s pioneering efforts in this field provide hope for healing. Join us for an enlightening discussion on the future of neurology, innovative treatments, and the remarkable journey of Solaxa.
CEO & Founder Christian Walker has focused his last twenty years pursuing the commercialization of nerve injury solutions. Christian’s fundraising experience spans raising money for start-ups, being a start-up venture capitalist, and securing significant non-dilutive financing through grants. At Christian’s prior start-ups, Christian was directly responsible for securing $11M in venture financing. While at Toucan Capital, he served as Principal of a $140 million venture capital fund focused on early-stage investments in stem cells and regenerative medicine. At Johns Hopkins and Walter Reed, he helped secure $22.5M in non-dilutive grants.
Luis T. Gutierrez, Jr. serves as Chief Operating Officer of Solaxa while also serving as an Executive in Residence with BioHealth Innovation. In both roles, he leverages his 25+ years of expertise in helping novel medical technologies with scientific and clinical promise transition to becoming successful commercial enterprises. He previously served in executive roles with Veranex, Theralink Technologies, Aptiv Solutions, and Covance.
Chief Commercial Officer Jennifer Butler has 25 years of broad biotechnology industry experience. Her commercial roles at MedImmune, AstraZeneca, and Innate have equipped her with a deep understanding of commercial execution at large and emerging biopharma. Notably, Jen launched Innate’s first commercial product in a rare oncology population. Jennifer also is also serving as an Executive in Residence with BioHealth Innovation.
Building Baltimore's Future: Kory Bailey and the UpSurge Vision
John Sackett - Execuitve Vice President & COO, Adventist Healthcare
Empowering Change: Lance Kawaguchi's Journey with the Cure Brain Cancer Foundation
Nanochon's Orthopedic Revolution: A New Era in Cartilage Restoration
Navigating the AI Wave: Dr. Juergen Klenk Explores AI's Reality in the BioHealth Industry
Pioneering Solutions: Dr. Nehal Mehta's Quest to Combat Chronic Diseases at Mobius Scientific
Investing in BioHealth: Blackbird Labs Vision with CEO Matt Tremblay
Breaking Barriers in Enteral Nutrition: Luminoah's Innovative MedTech with Neal Piper
Driving Cancer Research Innovation: A Conversation with Michael Weingarten, Director, SBIR Development Center at the National Cancer Institute (NCI)
Unlocking the Future of Stem Cell Research with MSCRF: A Conversation with Ruchika Nijhara, PhD, Executive Director of Maryland Stem Cell Research Fund (MSCRF)
Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies
Navigating the Future of Autoimmune Medicine: A Conversation with Dr. Theresa Podrebarac, Senior Vice President, Clinical Development at Horizon Therapeutics
Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO
Nurturing Tomorrow's STEM Leaders: A Conversation with Dr. Judy Staveley, Biotechnologist and STEM Advocate
BioTalk Discusses Breaking Frontiers in Immunotherapy: A Conversation with Bill Enright, CEO and Board Director at Vaccitech
How the BioHealth Capital Region Became a Top 3 BioPharma Cluster: Insights from Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News
Navigating Growth and Collaboration in Life Sciences: A Conversation with Brad L. Stewart, SVP of Business Development, MCEDC
Building Better Medicine, and Transformative Partnerships: Insights from Joy Polefrone, Ph.D. on BioTalk
Trailblazing in the BioHealth Capital Region: A Conversation with MedTech Innovator Accelerator Company Leaders
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money